Doximity: The US Physician Network for Pharma Media
US HCP network with NPI-verified members. The reference for US reach, without a DACH data basis.
Platform profile
- Platform type
- HCP network
- Regions
- US
- Channels
- Newsfeedprofessional newsletterstelehealth environments
- Managed service
- Yes
Measurement
- Audience verification on the member base
- Rx lift studies via partners (vendor claim, US)
Healthcare constraints
US frame (NPI registry, US pharma regulation). For every campaign: legal and compliance review required; the model has no equivalent in the GDPR space.
Limitations
- US only, no DACH data basis.
- No self-serve; booking via insertion orders.
- No programmatic access through external DSPs.
A fit when
- US campaigns with HCP focus, run from a global pharma setup.
- Specialty-precise reach among verified US physicians.
Not a fit when
- Your audience sits in DACH, where Doximity has no member base.
- You need self-serve or programmatic access.
The assessment
Doximity is the largest professional network for US physicians; by its own account it reaches most of the US medical profession. Members are verified against the NPI registry, and ad placements sit in the newsfeed, professional newsletters and around telehealth tools. Our view: the cleanest HCP identity in the US market. Nowhere else.
Audience model and targeting
The basis is membership instead of ad IDs: verified profiles with specialty, region and hospital affiliation. Targeting runs, per the vendor, on specialty, geography and further professional attributes. Data sources are registry and profile data; prescription data is not part of the targeting itself.
Activation and measurement
Buying is managed via insertion orders. External DSP access? None. On measurement the vendor names audience verification and Rx lift studies via partners. Little of that can be recomputed independently; teams that want their own attribution need clean click-to-CRM chains.
Compliance and review
Before any booking: legal and compliance review required. The setup lives in the US regulatory frame; statements about data conformity are vendor claims, not findings of ours. For EU constellations the model lacks the foundation, see Article 9 GDPR.
Common implementation mistakes
- Click destinations without UTM discipline, so the measurement chain ends at the portal.
- US campaign KPIs transferred to EU planning without validation.
- No own conversion tracking behind the insertion order.
Related platforms
The category map lives in the healthcare media comparison. More programmatic in access: Doceree; with real DACH reach: Medscape.
Sources
- Doximity (vendor) (accessed 2026-07-06)
Related services
Topical context
- Doximity advertising
- US HCP network
- pharma media USA
Do your conversions actually arrive in the ads platforms? The Paid Media Tracking Audit settles it.
Request a Paid Media Audit →More integrations we work with
- Ads & Conversion APIsDocereeHCP ad network with programmatic access and ID resolution. US-first, EU presence building out.
- Ads & Conversion APIsVeeva CrossixMeasurement partner for US pharma media. Not buying but impact measurement on US health data.
- Ads & Conversion APIsMedscapeGlobal HCP portal from the WebMD group, with a German edition. One of the few routes to DACH physicians.
- Ads & Conversion APIsSermoGlobal physician community with panels and ad environments, EU included. Strong for insights, slimmer for reach.
- Ads & Conversion APIsOptimizeRxUS platform for messages inside EHR and e-prescribing workflows. Maximum clinical context, zero DACH transferability.
- Ads & Conversion APIsPatientPointPoint-of-care screens in US practices and clinics. Venue targeting without personal data, the pattern with DACH lessons.